跳至主要内容
临床试验/ISRCTN26261491
ISRCTN26261491已完成未知

A pilot, randomised single blind study to evaluate the utility and efficacy of neutral argon plasma as a new technology in achieving complete cytoreduction of advanced epithelial ovarian carcinoma - initial feasibility study

Royal Surrey County Hospital NHS Foundation Trust (UK)0 个研究点目标入组 150 人开始时间: 2014年5月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Imaging+/- Clinical +/- laparoscopic e/o pelvic mass and metastatic disease (FIGO III/IV disease) at presentation
  • 2. Confirmation of malignancy on histological/cytological criteria
  • 3. All women aged 18 or over with newly diagnosed FIGO stage III to Stage IV EOC undergoing surgical treatment
  • 4. All women fit to undergo treatment
  • 5. No synchronous malignancy likely to interfere with comparisons
  • 6. Written and informed patient consent

排除标准

  • 1. Patient choice
  • 2. Patient unfit for any treatment modality
  • 3. Patients who are medically unfit for surgery and would only be suitable for chemotherapy

研究者

发起方
Royal Surrey County Hospital NHS Foundation Trust (UK)

相似试验